Stefan Ryser
2009
In 2009, Stefan Ryser earned a total compensation of $392.5K as Former Senior Vice President, Corporate Strategy at MabVax Therapeutics Holdings, a 7% increase compared to previous year.
Compensation breakdown
| Salary | $189,583 |
|---|---|
| Other | $202,922 |
| Total | $392,505 |
Ryser received $202.9K in other compensation, accounting for 52% of the total pay in 2009.
Ryser also received $189.6K in salary.
Rankings
In 2009, Stefan Ryser's compensation ranked 7,618th out of 9,885 executives tracked by ExecPay. In other words, Ryser earned more than 22.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,618 out of 9,885 | 23rd |
Division Manufacturing | 2,844 out of 3,690 | 23rd |
Major group Chemicals And Allied Products | 644 out of 866 | 26th |
Industry group Drugs | 460 out of 638 | 28th |
Industry Pharmaceutical Preparations | 341 out of 446 | 24th |
Source: SEC filing on April 7, 2010.
Ryser's colleagues
We found four more compensation records of executives who worked with Stefan Ryser at MabVax Therapeutics Holdings in 2009.
2009
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2009
Cynthia Butitta
MabVax Therapeutics Holdings
Chief Financial Officer
2009
Marc Steuer
MabVax Therapeutics Holdings
Senior Vice President, Business Development
2009
William Kaplan
MabVax Therapeutics Holdings